What’s Cellect Biotechnology Limited Ads (NASDAQ:APOP) Upside After This Short Interest Decrease?

October 13, 2017 - By Migdalia James

 What's Cellect Biotechnology Limited Ads (NASDAQ:APOP) Upside After This Short Interest Decrease?

The stock of Cellect Biotechnology Limited Ads (NASDAQ:APOP) registered a decrease of 5.89% in short interest. APOP’s total short interest was 124,600 shares in October as published by FINRA. Its down 5.89% from 132,400 shares, reported previously. With 22,800 shares average volume, it will take short sellers 6 days to cover their APOP’s short positions. The short interest to Cellect Biotechnology Limited Ads’s float is 3.97%.

The stock increased 3.32% or $0.26 on October 13, reaching $8.08. About shares traded. Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

More recent Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ:APOP) news were published by: Streetinsider.com which released: “Cellect Biotechnology (APOP) IPO Opens Lower” on July 29, 2016. Also Prnewswire.com published the news titled: “Cellect Biotechnology Announces $4.3 Million Raise in a Registered Direct Offering” on September 07, 2017. Prnewswire.com‘s news article titled: “Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter …” with publication date: August 21, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.